feed,title,long_url,short_url
MedRxiv,"Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From the CANOPY Clinical Trial",https://medrxiv.org/cgi/content/short/2024.11.11.24317127v1?rss=1,https://da.gd/F2UwO
MedRxiv,"Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up",https://medrxiv.org/cgi/content/short/2024.11.13.24317190v1?rss=1,https://da.gd/dVaLD
